Clinical Trial Update: A Study of Basal Insulin Analog and Insulin Analog Mid Mixture in Chinese Participants With Type 2 Diabetes Mellitus [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating basal insulin analog and insulin analog mid mixture in Chinese patients with type 2 diabetes mellitus completed with posted resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Basal insulin analog
• Insulin analog mid mixture

Snippet

Sponsor: Eli Lilly and Company | Conditions: Type 2 Diabetes Mellitus | Phase 4 | Status: COMPLETED | Results posted: 2020-03-18